Company intelligence / Profile preview

GinsenoLife Sciences

Orlando, Florida, United Statesginsenolife.com ↗
Ownership
Private
Employees
~5
Development stage
Other
01

Overview

GinsenoLife Sciences is a clinical-stage biotechnology company dedicated to the development of therapies for rare lysosomal storage diseases and neurodegenerative conditions. The company utilizes a proprietary platform to develop synthetic derivatives of ginsenosides, which are bioactive compounds found in ginseng. Its lead candidate, GLS-102, is being investigated for the treatment of Niemann-Pick Disease Type C, a fatal genetic disorder characterized by the inability of the body to transport cholesterol and other lipids. GinsenoLife's research is rooted in discoveries made at the University of Central Florida, focusing on the neuroprotective and metabolic regulatory properties of its compounds. The company aims to provide disease-modifying options for patients with high unmet medical needs.

Therapeutic areas
NeurologyRare Diseases
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on GinsenoLife Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GinsenoLife Sciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call